KK-220

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameKK-220
Drug Alias NameDianexin ophthalmic - KowaRecombinant human annexin A5 ophthalmic - KowaKK-220
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUrokinase plasminogen activator stimulants
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKowa Dental Health Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKowa Dental Health Co Ltd
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A